The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label, phase 2 study of adebrelimab combined with fuzuloparib in the treatment of patients with HRD-positive, recurrent platinum-resistant ovarian cancer.
 
Jian Chen
No Relationships to Disclose
 
JianPing Zou
No Relationships to Disclose
 
Haijuan Yu
No Relationships to Disclose
 
Li Liu
No Relationships to Disclose
 
Lele Zang
No Relationships to Disclose
 
Yang Sun
No Relationships to Disclose